Discussion about this post

User's avatar
Ben Fen's avatar

Excellent! Johns Hopkins scientists have shown that mebendazole disrupts the shield of cells, called the stroma, protecting pancreatic tumors that make therapeutic treatment difficult Williamson, T., de Abreu, M. C., Trembath, D. G., Brayton, C., Kang, B., Mendes, T. B., de Assumpção, P. P., Cerutti, J. M., & Riggins, G. J. (2021). Mebendazole disrupts stromal desmoplasia and tumorigenesis in two models of pancreatic cancer. Oncotarget, 12(14), 1326–1338. https://doi.org/10.18632/oncotarget.28014. While mebendazole is effective, Italian scientists have shown that fenbendazole is actually the more effective pancreatic cell killer https://www.mdpi.com/2072-6694/11/12/2042

Doctor Samizdat's avatar

After performing around 400 pancreatic resections (and a similar number of hepatobiliary, gastroesoohageal and rectal resections) and watched disease progression (primarily in the upper GI cancers), I concluded that surgery was not integral to the treatment of most of these cases save for palliation of symptoms and that the future is with systemic therapy. The NCI is (finally) considering an Ivermectin trial but it likely will be too little, too late. I focus on breast cancer and melanoma now, dedicating my time to helping patients avoid radical surgery, as they mostly are also "medical" and not "surgical" cancers. The public's mindset favoring radical surgery is tough to break, however. "Modern" medicine has largely done a disservice to the man on the street.......

12 more comments...

No posts

Ready for more?